article thumbnail

PPC Campaign Optimization for Pharma: Boosting ROI

Pharma Marketing Network

Leverage first-party data to refine retargeting strategies while maintaining HIPAA compliance. FDA and HIPAA Compliance in PPC Fair balance requirements Ads must include benefits and risks equally. No unapproved drug claims All claims must be backed by clinical research and FDA-approved labeling.

HIPAA 59
article thumbnail

Why Pharma Marketers Are Interested in Real-Time Bidding

Pharma Marketing Network

HIPAA regulations, FDA guidelines, and state-level data privacy laws require careful consideration. Ad creatives must be approved by legal and medical review teams to meet FDA labeling requirements. Yes, when executed with anonymized data and reviewed creative, RTB can meet HIPAA and FDA guidelines.

HIPAA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmaceutical Marketing in 2025: Trends, Tech, and Targeting That Matter Most

Pharma Marketing Network

As automation becomes smarter, ensuring HIPAA and GDPR compliance remains critical. Leveraging tools that enable real-time content approval and centralized tracking can prevent outdated messaging or off-label promotion. However, marketers must balance innovation with privacy.

HIPAA 52
article thumbnail

How Has Social Media Advertising Changed in Pharma

Pharma Marketing Network

The emergence of HIPAA-compliant targeting technologies, HCP-specific segments, and improved analytics has made social platforms not just viable but essential for pharmaceutical marketing. While off-label promotion is still strictly regulated, unbranded awareness campaigns have found creative footing. It’s a strategic pillar.

HIPAA 52
article thumbnail

Pharma Email Marketing Solutions for Large Lists

Pharma Marketing Network

For starters, every email must comply with HIPAA, CAN-SPAM, and FDA regulations. Missteps in off-label promotion or data security can trigger legal and reputational risks. While email remains a powerful tool for engaging healthcare professionals and patients, it’s subject to unique constraints.

HIPAA 52
article thumbnail

Email Marketing Campaigns for Pharma: Boost Engagement & Compliance

Pharma Marketing Network

Challenges in Pharma Email Marketing Pharma brands face unique barriers that other industries dont , such as: Strict compliance regulations (FDA, GDPR, HIPAA) that limit messaging. Drug names and indications must align with FDA-approved labeling. Email fatigue among HCPs and patients , leading to low open rates.

HIPAA 72
article thumbnail

Basics in Programmatic Display Ads

Pharma Marketing Network

Compliance and Best Practices Adhere to Regulations: Pharma marketers must ensure that their programmatic campaigns comply with regulations such as HIPAA and FDA guidelines. This includes safeguarding patient data and avoiding off-label promotion. How can pharma marketers ensure compliance in programmatic campaigns?

HIPAA 52